$NNVC ripping premarket 🚀 Up 37% 🔹 NanoViricides is a clinical-stage antiviral biotech developing broad-spectrum nanomedicine treatments 🧬 🔹 Momentum tied t

$NNVC ripping premarket 🚀 Up 37% 🔹 NanoViricides is a clinical-stage antiviral biotech developing broad-spectrum nanomedicine treatments 🧬 🔹 Momentum tied to NV-387, its lead antiviral candidate advancing toward Phase II trials 💥 🔹 Recent FDA Orphan Drug Designation for NV-387 in measles adds …